Article
Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations.
The Journal of rheumatology - 1 Nov 2002
Morse Jane, Barst Robyn, Horn Evelyn, Cuervo Nieves, Deng Zemin, Knowles James
Abstract excerpt
OBJECTIVE: To determine whether mutations in the bone morphogenetic protein receptor 2 gene (BMPR2), initially reported in primary pulmonary hypertension, were present in patients with pulmonary arterial hypertension and scleroderma spectrum of disease. Methods. BMPR2 gene mutations were determin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
